Incidence and risk factors of admission deep venous thrombosis in nonagenarians and centenarians with intertrochanteric fracture: a retrospective study

J Orthop Surg Res. 2023 Aug 2;18(1):558. doi: 10.1186/s13018-023-04032-9.

Abstract

Purpose: The objective of this study was to identify the risk factors for admission deep venous thrombosis (aDVT) and proximal aDVT in nonagenarians and centenarians with intertrochanteric fracture (IF).

Methods: We collected statistics on nonagenarians and centenarians with IF admitting from January 2010 to October 2022. Patients with aDVT were considered as the aDVT group and those without aDVT as the non-aDVT group. Additionally, we also conducted a subgroup analysis based on the location of aDVT to investigate the predictors of proximal aDVT. The demographics, comorbidities and admission laboratory examinations of patients were computed by univariate analysis, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis.

Results: In our study, the rate of aDVT (109 of 318) was 34.3%, and 5.7% (18 of 318) of patients had proximal aDVT. Logistic regression analysis showed that female patients and a high level of D-dimer were risk factors for aDVT. Similarly, hypoproteinemia and a high level of D-dimer were found to be risk factors for proximal aDVT. ROC curve analysis indicated the cut-off values of D-dimer to predict the aDVT and proximal aDVT were 1.28 mg/L and 1.485 mg/L, respectively.

Conclusions: Our findings investigated the risk factors of aDVT and proximal aDVT in nonagenarians and centenarians with IF and identified the cut-off values of D-dimer, helping us assess the risk of aDVT and proximal aDVT to manage early targeted interventions.

Keywords: D-dimer; Deep venous thrombosis; Intertrochanteric fracture; Nonagenarians and centenarians.

MeSH terms

  • Aged, 80 and over
  • Centenarians
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Hip Fractures* / complications
  • Hip Fractures* / epidemiology
  • Humans
  • Incidence
  • Nonagenarians
  • Retrospective Studies
  • Risk Factors
  • Venous Thrombosis* / epidemiology
  • Venous Thrombosis* / etiology

Substances

  • Fibrin Fibrinogen Degradation Products